Alliance A021806: A phase III trial evaluating perioperative versus adjuvant therapy for resectable pancreatic cancer.

被引：0
|
作者：
Chawla, Akhil
Shi, Qian
Ko, Andrew H.
Beg, Shaalan
Varghese, Anna M.
Behrman, Stephen W.
Bloomston, Mark
Ahmed, Firas Salem
Frankel, Wendy L.
Dixon, Jesse G.
Carrero, Xiomara W.
Shergill, Ardaman
Crawley, Jamie
Akin, Oguz
Renouf, Daniel John
Zogopoulos, George
Hubbard, Joleen M.
Meyerhardt, Jeffrey A.
O'Reilly, Eileen Mary
Ferrone, Cristina R.
机构：
[1] Northwestern Univ, Robert H Lurie Comprehens Canc, Chicago, IL USA
[2] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA
[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[4] UT Southwestern Simmons Canc Ctr, Dallas, TX USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY USA
[6] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[7] South Florida Surg Oncol, Ft Myers, FL USA
[8] Columbia Univ, Med Ctr, New York, NY USA
[9] Ohio State Univ, Arthur G James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA
[10] Univ Chicago, Sect Hematol & Oncol, Dept Med, Med Ctr, Chicago, IL USA
[11] Univ Chicago, Chicago, IL USA
[12] Univ British Columbia, BC Canc Agcy, Vancouver, BC, Canada
[13] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[14] Mayo Clin, Dept Med Oncol, Rochester, MN USA
[15] Alliance Clin Trials Oncol, Chicago, IL USA
[16] Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4204
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Postoperative Complications Following Neoadjuvant Therapy and Surgery in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)
    Snyder, Rebecca A.
    Zemla, Tyler J.
    Shi, Qian
    Segovia, Diana
    Ahmad, Syed A.
    O'Reilly, Eileen
    Herman, Joseph M.
    Katz, Matthew H. G.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S24 - S24
  • [22] Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
    Alice C. Wei
    Fang-Shu Ou
    Qian Shi
    Xiomara Carrero
    Eileen M. O’Reilly
    Jeffrey Meyerhardt
    Robert A. Wolff
    Hedy L. Kindler
    Douglas B. Evans
    Vikram Deshpande
    Joseph Misdraji
    Eric Tamm
    Dushyant Sahani
    Malcolm Moore
    Elliot Newman
    Nipun Merchant
    Jordan Berlin
    Laura W. Goff
    Peter Pisters
    Mitchell C. Posner
    Annals of Surgical Oncology, 2019, 26 : 4489 - 4497
  • [23] Postoperative complications following neoadjuvant therapy and surgery in a phase 2 borderline resectable pancreatic cancer clinical trial (Alliance A021501).
    Snyder, Rebecca A.
    Zemla, Tyler J.
    Shi, Qian
    Segovia, Diana I.
    Ahmad, Syed
    O'Reilly, Eileen Mary
    Herman, Joseph M.
    Katz, Matthew H. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 664 - 664
  • [24] Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial
    J. L. van Dam
    E. M. M. Verkolf
    E. N. Dekker
    B. A. Bonsing
    S. O. Bratlie
    L. A. A. Brosens
    O. R. Busch
    L. M. J. W. van Driel
    C. H. J. van Eijck
    S. Feshtali
    P. Ghorbani
    D. J. A. de Groot
    J. W. B. de Groot
    B. C. M. Haberkorn
    I. H. de Hingh
    B. van der Holt
    T. M. Karsten
    M. B. van der Kolk
    K. J. Labori
    M. S. L. Liem
    O. J. L. Loosveld
    I. Q. Molenaar
    M. B. Polée
    H. C. van Santvoort
    J. de Vos – Geelen
    M. L. Wumkes
    G. van Tienhoven
    M. Y. V. Homs
    M. G. Besselink
    J. W. Wilmink
    B. Groot Koerkamp
    BMC Cancer, 23
  • [25] Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial
    van Dam, J. L.
    Verkolf, E. M. M.
    Dekker, E. N.
    Bonsing, B. A.
    Bratlie, S. O.
    Brosens, L. A. A.
    Busch, O. R.
    van Driel, L. M. J. W.
    van Eijck, C. H. J.
    Feshtali, S.
    Ghorbani, P.
    de Groot, D. J. A.
    de Groot, J. W. B.
    Haberkorn, B. C. M.
    de Hingh, I. H.
    van der Holt, B.
    Karsten, T. M.
    van der Kolk, M. B.
    Labori, K. J.
    Liem, M. S. L.
    Loosveld, O. J. L.
    Molenaar, I. Q.
    Polee, M. B.
    van Santvoort, H. C.
    de Vos Geelen, J.
    Wumkes, M. L.
    van Tienhoven, G.
    Homs, M. Y. V.
    Besselink, M. G.
    Wilmink, J. W.
    Groot Koerkamp, B.
    BMC CANCER, 2023, 23 (01)
  • [26] Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
    Wang, Xinxin
    Lu, Canrong
    Wei, Bo
    Li, Shuo
    Li, Ziyu
    Xue, Yingwei
    Ye, Yingjiang
    Zhang, Zhongtao
    Sun, Yihong
    Liang, Han
    Li, Kai
    Zhu, Linghua
    Zheng, Zhichao
    Zhou, Yanbing
    He, Yulong
    Li, Fei
    Wang, Xin
    Liang, Pin
    Huang, Hua
    Li, Guoli
    Shen, Xian
    Ji, Jiafu
    Tang, Yun
    Xu, Zekuan
    Chen, Lin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01) : 17
  • [27] Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
    Xinxin Wang
    Canrong Lu
    Bo Wei
    Shuo Li
    Ziyu Li
    Yingwei Xue
    Yingjiang Ye
    Zhongtao Zhang
    Yihong Sun
    Han Liang
    Kai Li
    Linghua Zhu
    Zhichao Zheng
    Yanbing Zhou
    Yulong He
    Fei Li
    Xin Wang
    Pin Liang
    Hua Huang
    Guoli Li
    Xian Shen
    Jiafu Ji
    Yun Tang
    Zekuan Xu
    Lin Chen
    Journal of Hematology & Oncology, 17
  • [28] A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer.
    Neuhaus, P
    Oettle, H
    Post, S
    Gellert, K
    Ridwelski, K
    Schramm, H
    Zülke, C
    Fahlke, G
    Langrehr, J
    Riess, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1092S - 1092S
  • [29] Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study
    Seufferlein, T.
    Uhl, W.
    Alguel, H.
    Friess, H.
    Kornmann, M.
    Koenig, A. O.
    Ghadimi, M.
    Gress, T. M.
    Lutz, M. P.
    Wille, K.
    Schimanski, C.
    Kunzmann, V.
    Berger, A.
    Schuhbaur, J.
    Perkhofer, L.
    Blome, L.
    Tannapfel, A.
    Tempero, M. A.
    Reinacher-Schick, A.
    Ettrich, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1333 - S1333
  • [30] Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial.
    Van Tienhoven, Geertjan
    Versteijne, Eva
    Suker, Mustafa
    Groothuis, Karin B. C.
    Busch, Olivier R.
    Bonsing, Bert A.
    de Hingh, Ignace H. J. T.
    Festen, Sebastiaan
    Patijn, Gijs A.
    de Vos-Geelen, Judith
    Zwinderman, Aeilko H.
    Punt, Cornelis J. A.
    van Eijck, Casper H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18)
12345